AstraZeneca PLC CEDEAR (AZN)

Profile

https://www.astrazeneca.com

AstraZeneca PLC CEDEAR is a certificate representing shares of AstraZeneca PLC, a Swedish-British multinational pharmaceutical and biotechnology company headquartered in Cambridge, United Kingdom. The company focuses on the discovery, development, manufacture, and commercialization of prescription medicines across key therapeutic areas including oncology, rare diseases, biopharmaceuticals, cardiovascular, renal and metabolism, respiratory and immunology, as well as vaccines and immune therapies. Its portfolio encompasses innovative medicines targeting major diseases such as cancer, diabetes mellitus, asthma, COPD, and influenza, with products serving primary care, specialty care, and global healthcare needs. AstraZeneca PLC maintains a robust global presence, operating research and development centers in Cambridge, UK; Gaithersburg, Maryland, US; Gothenburg, Sweden; and other locations, while distributing through local representatives and partnerships worldwide. Founded in 1992, it plays a significant role in addressing non-communicable diseases and supports access initiatives in various regions.